Profile
STRR DHR-PB TMO DHR IDXX A
Company Name Star Equity Holdings, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $32.79M $916.76B $185.56B $139.15B $51.04B $35.86B
Employees 0.19K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Richard Kenneth Coleman Jr. Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
STRR DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
STRR DHR-PB TMO DHR IDXX A
Last Close $9.37 $1261.26 $479.46 $190.05 $641.14 $123.24
High 52 $9.37 $1261.26 $620.25 $278.02 $682.78 $152.6
Low 52 $1.8 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High 0 % 0 % -22.7 % -31.64 % -6.1 % -19.24 %
Price vs. 52 Week Low 420.56 % 0 % 22.88 % 8.82 % 77.58 % 24.12 %
Total Return
STRR DHR-PB TMO DHR IDXX A
1 Month Return 327.85 % 0 % -1.18 % -9.56 % -1.96 % 3.68 %
3 Month Return 373.23 % 0 % 19.04 % -5.29 % 22.66 % 5.26 %
6 Month Return 327.85 % 0 % -8.16 % -9.82 % 54.38 % 1.7 %
9 Month Return 256.8 % 0 % -9 % -19.09 % 48.38 % -11.34 %
YTD Return 314.6 % 0 % -7.84 % -17.21 % 55.07 % -8.26 %
1 Year Return 127.43 % 0 % -21.55 % -30.7 % 28.09 % -10.25 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
STRR DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.6 % 0.33 % 0.61 % - 0.78 %
Dividend Paid and Capex Coverage Ration (TTM) -0.35 % 2.91 % 3.76 % 2.91 % 6.89 % 4.01 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.18 % - 0.98 %
Payout Ratio (TTM) -103.81 % 23.85 % 9.26 % 23.85 % - 22.95 %
Profitability
STRR DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 24.71 % 61.52 % 39.58 % 61.52 % 61.54 % 52.96 %
Return on Assets TTM -3.87 % 4.18 % 6.5 % 4.18 % 29.59 % 9.98 %
Return on Equity TTM -5.28 % 6.69 % 13.27 % 6.69 % 64.42 % 19.97 %
Return on Capital Employed TTM -13.4 % 6.93 % 8.97 % 6.93 % 59.57 % 13.97 %
Net Income Per EBT TTM 59.48 % 83.73 % 93.8 % 83.73 % 80.28 % 87.52 %
EBT Per Ebit TTM 65.32 % 78.61 % 88.39 % 78.61 % 97.81 % 96.54 %
EBIT Per Revenue TTM -8.22 % 21.59 % 18.38 % 21.59 % 31.09 % 21.27 %
Cash Flow To Debt Ratio TTM -212.15 % 33.25 % 21.51 % 33.25 % 73.21 % 43.85 %
Receivables Turnover TTM 2.86 5.32 4.31 5.32 6.09 4.91
Payables Turnover TTM 21.65 5.36 8.76 5.36 13.32 6.02
Inventory Turnover TTM - 3.44 4.7 3.44 3.96 3.15
Fixed Asset Turnover TTM 5750 % 374.68 % 448.49 % 374.68 % 464.4 % 345.27 %
Asset Turnover TTM 121.26 % 29.42 % 42.69 % 29.42 % 121.22 % 55.52 %
Operating Cash Flow Per Share TTM -0.64 8.61 20.05 8.61 11.26 5.25
Free Cash Flow Per Share TTM -1.79 6.79 16.32 6.79 9.63 4.92
Cash Per Share TTM 525.34 % 412.7 % 1690.48 % 412.7 % 204.69 % 538.6 %
Operating Cash Flow Sales Ratio TTM -3.06 % 25.69 % 17.54 % 25.69 % 22.43 % 22.02 %
Free Cash Flow Operating Cash Flow Ratio TTM 279.17 % 78.81 % 81.42 % 78.81 % 85.49 % 93.78 %
Cash Flow Coverage Ratios TTM -212.15 % 33.25 % 21.51 % 33.25 % 73.21 % 43.85 %
Price To Free Cash Flows Ratio TTM -5.7 28.74 30.07 28.62 65.91 25.58
Price To Operating Cash Flows Ratio TTM -14.58 22.67 24.51 22.57 56.63 24.07
Price Cash Flow Ratio TTM -14.58 22.67 24.51 22.57 56.63 24.07
Income Statement (TTM)
STRR DHR-PB TMO DHR IDXX A
Revenue $0.05B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0.01B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio 20.72% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -3.97 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
STRR DHR-PB TMO DHR IDXX A
Long Term Debt $0B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $0.01B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.04B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $0.05B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
STRR DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $-0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 123.24
ACRS Aclaris Therapeutics, Inc. 1.95
ADVB Advanced Biomed Inc. Common Stock 0.5181
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 2.68
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.3751
BIAF bioAffinity Technologies, Inc. 0.27
BIAFW bioAffinity Technologies, Inc. 0.07
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.88
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 8.3
CDNA CareDx, Inc 13.53
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.7459
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 152.89
CSTL Castle Biosciences, Inc. 21.42
ETFs With Exposure to STRR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 324.31
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 143.97
VXF Vanguard Extended Market Index Fund 0.00003 208.84
DFAT Dimensional U.S. Targeted Value ETF 0.00021038 58.86
DFAS Dimensional U.S. Small Cap ETF 0.00014456 68.55
VTSAX Vanguard Total Stock Market Index Fund 0 157.86
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 158.47
VITSX Vanguard Total Stock Market Index Fund 0 157.89
DFSU Dimensional US Sustainability Core 1 ETF 0.00004084 42.0542
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 158.48
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 391.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 296.18
Unlock